A detailed history of Perigon Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 2,570 shares of MRNA stock, worth $168,977. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,570
Previous 2,393 7.4%
Holding current value
$168,977
Previous $254,000 20.08%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$101.21 - $166.61 $17,914 - $29,489
177 Added 7.4%
2,570 $305,000
Q1 2024

Apr 29, 2024

BUY
$85.37 - $115.44 $204,290 - $276,247
2,393 New
2,393 $254,000
Q3 2023

Oct 30, 2023

SELL
$96.41 - $126.61 $18,317 - $24,055
-190 Reduced 7.88%
2,220 $229,000
Q2 2023

Aug 02, 2023

SELL
$118.5 - $160.53 $2,962 - $4,013
-25 Reduced 1.03%
2,410 $292,000
Q1 2023

May 03, 2023

BUY
$135.66 - $197.02 $4,883 - $7,092
36 Added 1.5%
2,435 $373,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $246,348 - $437,093
-2,081 Reduced 46.45%
2,399 $430,000
Q3 2022

Dec 13, 2022

SELL
$118.07 - $194.18 $313,121 - $514,965
-2,652 Reduced 37.18%
4,480 $530,000
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $56,105 - $84,586
479 Added 7.2%
7,132 $1.02 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $662,144 - $1.23 Million
5,236 Added 369.51%
6,653 $1.15 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $13,097 - $21,373
58 Added 4.27%
1,417 $360,000
Q3 2021

Nov 01, 2021

BUY
$221.9 - $484.47 $301,562 - $658,394
1,359 New
1,359 $523,000
Q3 2021

Oct 25, 2021

SELL
$221.9 - $484.47 $256,294 - $559,562
-1,155 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$129.91 - $234.98 $150,046 - $271,401
1,155 New
1,155 $271,000
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $95,969 - $163,476
-879 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$65.74 - $169.86 $57,785 - $149,306
879 New
879 $92,000
Q3 2011

Nov 14, 2022

SELL
N/A
-2,652
4,480 $530,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.